688331.SH
荣昌生物
SSE · Healthcare · Biotechnology · CN
CNY 116.42
−7.24%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 24, 2026
- EPS actual
- CNY 7.74
- EPS estimate
- —
- Revenue actual
- CNY 5.1B
- Revenue estimate
- CNY 2.7B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026